<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32371347</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-1244</ISSN><JournalIssue CitedMedium="Internet"><Volume>77</Volume><PubDate><Year>2020</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Nutrition (Burbank, Los Angeles County, Calif.)</Title><ISOAbbreviation>Nutrition</ISOAbbreviation></Journal><ArticleTitle>Increased resting energy expenditure compared with predictive theoretical equations in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>110805</StartPage><MedlinePgn>110805</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nut.2020.110805</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0899-9007(20)30088-5</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Approximately 50% to 60% of amyotrophic lateral sclerosis (ALS) is characterized by an increase in metabolic rate. The Harris and Benedict (HB) 1919 formula is the equation mainly used to calculate resting energy expenditure (cREE) compared with measured REE (mREE) by indirect calorimetry (IC), but other formulas are also applied in current practice. The present study aimed to assess mREE in patients with ALS compared with 12 cREE formulas and study the relevant threshold of REE variation to screen patients with a higher evolving risk.</AbstractText><AbstractText Label="METHODS">Nutritional assessments and body composition (by bioimpedance analysis) were performed in patients with ALS. mREE was measured by IC, and cREE was calculated using the HB 1919, HB 1984, World Schofield, De Lorenzo, Johnstone, Mifflin, World Health Organization/Food and Agriculture Organization, Owen, Fleisch, Wang, Rosenbaum, and Nelson formulas. Functional and respiratory evolution and survival by log-rank test according to two thresholds of REE variation (10% and 20%) were studied.</AbstractText><AbstractText Label="RESULTS">A total of 315 patients with ALS were included in the study. The median mREE was 1503 kcal/24 h (range, 1290-1698 kcal/24 h), which was higher than all predictive equations (P &lt; 0.0001). Depending on the predictive equation, REE variation &gt;10% and 20% was found in 35.2% to 76.3% and 14.6% to 53.3% of patients with ALS, respectively. Patients with an REE variation &gt;20% with HB 1919 and HB 1984 had a lower survival. Moreover, with this same threshold and the Mifflin formula, patients had higher functional and respiratory evolutions and lower survival.</AbstractText><AbstractText Label="CONCLUSIONS">The increase in metabolic rate is present according to the different cREE formulas used compared with IC. In clinical practice, REE formulas (e.g., HB 1919, HB 1984, or Mifflin) can be used as a reference value compared with IC to screen patients with ALS with an REE variation &gt;20% and a higher evolving risk.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>J&#xe9;sus</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Nutrition Unit, University Hospital of Limoges, Limoges, France; INSERM (Institut National de la Sant&#xe9; et de la Recherche M&#xe9;dicale), U1094, Tropical Neuroepidemiology, Limoges, France; University of Limoges, UMR_S 1094, Tropical Neuroepidemiology, Institute of Neuroepidemiology and Tropical Neurology, CNRS FR 3503 GEIST, Limoges, France. Electronic address: pierre.jesus@chu-limoges.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fayemendy</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Nutrition Unit, University Hospital of Limoges, Limoges, France; INSERM (Institut National de la Sant&#xe9; et de la Recherche M&#xe9;dicale), U1094, Tropical Neuroepidemiology, Limoges, France; University of Limoges, UMR_S 1094, Tropical Neuroepidemiology, Institute of Neuroepidemiology and Tropical Neurology, CNRS FR 3503 GEIST, Limoges, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marin</LastName><ForeName>Benoit</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>INSERM (Institut National de la Sant&#xe9; et de la Recherche M&#xe9;dicale), U1094, Tropical Neuroepidemiology, Limoges, France; University of Limoges, UMR_S 1094, Tropical Neuroepidemiology, Institute of Neuroepidemiology and Tropical Neurology, CNRS FR 3503 GEIST, Limoges, France; Center of Epidemiology, Biostatistics and Research Methodology, University Hospital of Limoges, Limoges, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicol</LastName><ForeName>Marie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>INSERM (Institut National de la Sant&#xe9; et de la Recherche M&#xe9;dicale), U1094, Tropical Neuroepidemiology, Limoges, France; University of Limoges, UMR_S 1094, Tropical Neuroepidemiology, Institute of Neuroepidemiology and Tropical Neurology, CNRS FR 3503 GEIST, Limoges, France; Amyotrophic lateral sclerosis center, University Hospital of Limoges, Limoges, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sourisseau</LastName><ForeName>Huguette</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Nutrition Unit, University Hospital of Limoges, Limoges, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boirie</LastName><ForeName>Yves</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Clermont Auvergne, CHU Clermont-Ferrand, Service de Nutrition Clinique, CRNH Auvergne, Clermont-Ferrand, France; Universit&#xe9; Clermont Auvergne, INRA, UNH, Unit&#xe9; de Nutrition Humaine, CRNH Auvergne, Clermont-Ferrand, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walrand</LastName><ForeName>St&#xe9;phane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Clermont Auvergne, INRA, UNH, Unit&#xe9; de Nutrition Humaine, CRNH Auvergne, Clermont-Ferrand, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Achamrah</LastName><ForeName>Najate</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Nutrition Department, Clinical Investigation Centre CIC-1404, University Hospital, Rouen, France; INSERM UMR 1073, Nutrition, Inflammation and Gut-Brain axis dysfunction, Normandie University, UNIROUEN, Rouen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Co&#xeb;ffier</LastName><ForeName>Mo&#xef;se</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Nutrition Department, Clinical Investigation Centre CIC-1404, University Hospital, Rouen, France; INSERM UMR 1073, Nutrition, Inflammation and Gut-Brain axis dysfunction, Normandie University, UNIROUEN, Rouen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Preux</LastName><ForeName>Pierre-Marie</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>INSERM (Institut National de la Sant&#xe9; et de la Recherche M&#xe9;dicale), U1094, Tropical Neuroepidemiology, Limoges, France; University of Limoges, UMR_S 1094, Tropical Neuroepidemiology, Institute of Neuroepidemiology and Tropical Neurology, CNRS FR 3503 GEIST, Limoges, France; Center of Epidemiology, Biostatistics and Research Methodology, University Hospital of Limoges, Limoges, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lautrette</LastName><ForeName>G&#xe9;raldine</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Amyotrophic lateral sclerosis center, University Hospital of Limoges, Limoges, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Couratier</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>INSERM (Institut National de la Sant&#xe9; et de la Recherche M&#xe9;dicale), U1094, Tropical Neuroepidemiology, Limoges, France; University of Limoges, UMR_S 1094, Tropical Neuroepidemiology, Institute of Neuroepidemiology and Tropical Neurology, CNRS FR 3503 GEIST, Limoges, France; Amyotrophic lateral sclerosis center, University Hospital of Limoges, Limoges, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desport</LastName><ForeName>Jean-Claude</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Nutrition Unit, University Hospital of Limoges, Limoges, France; INSERM (Institut National de la Sant&#xe9; et de la Recherche M&#xe9;dicale), U1094, Tropical Neuroepidemiology, Limoges, France; University of Limoges, UMR_S 1094, Tropical Neuroepidemiology, Institute of Neuroepidemiology and Tropical Neurology, CNRS FR 3503 GEIST, Limoges, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nutrition</MedlineTA><NlmUniqueID>8802712</NlmUniqueID><ISSNLinking>0899-9007</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001481" MajorTopicYN="N">Basal Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002153" MajorTopicYN="N">Calorimetry, Indirect</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004734" MajorTopicYN="N">Energy Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Evolution</Keyword><Keyword MajorTopicYN="N">Metabolic rate</Keyword><Keyword MajorTopicYN="N">Predictive equation</Keyword><Keyword MajorTopicYN="N">Resting energy expenditure</Keyword><Keyword MajorTopicYN="N">Survival</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32371347</ArticleId><ArticleId IdType="doi">10.1016/j.nut.2020.110805</ArticleId><ArticleId IdType="pii">S0899-9007(20)30088-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>